Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03127215 |
Title | Study of Olaparib/Trabectedin vs. Doctor's Choice in Solid Tumors (NCT-PMO-1603) |
Acronym | NCT-PMO-1603 |
Recruitment | Completed |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | National Center for Tumor Diseases, Heidelberg |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | DEU |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Medizinische Fakultät der TU Dresden | Dresden | 01307 | Germany | Details | ||
Universitätsklinikum Essen | Essen | 45147 | Germany | Details | ||
Universitätsklinikum Frankfurt | Frankfurt | 60590 | Germany | Details | ||
Universitätsklinikum Freiburg | Freiburg | 79106 | Germany | Details | ||
National Center for Tumordiseases (NCT) | Heidelberg | 69120 | Germany | Details | ||
Universitätsmedizin der Johannes-Gutenberg-Universität Mainz | Mainz | 55131 | Germany | Details | ||
Klinikum der Universität München-Großhadern | München | 81377 | Germany | Details | ||
Klinik Schillerhöhe | Stuttgart | 70376 | Germany | Details | ||
Universitätsklinikum Tübingen | Tuebingen | 72076 | Germany | Details |